COVID-19 Pandemisi ve Diabetes Mellitus

Abstract

The COVID-19 pandemic, caused by SARS-CoV-2 of Coronaviruses types, is a highly infectious disease caused by SARS-CoV-2, which first appeared in China. The presence of comorbid diseases, especially diabetes, and advanced age are determinant for the mortality and morbidity of the disease. Considering the cellular mechanisms triggered by COVID-19 and the pathophysiology of diabetes, make individuals with diabetes more susceptible to a cytokine storm with potential organ damage. Studies have reported that individuals with diabetes and who have been infected by COVID-19 showed higher admission rates to hospitals, development of severe pneumonia as well as higher mortality rates, when compared to those without comorbidities. This risk can be reduced, though not completely eliminated, by good glycemic control. In patients with diabetes, both glycemic regulation and stabilization of comorbid conditions such as concomitant heart disease, hypertension, obesity or kidney disease should be provided.